Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use LATISSE safely and effectively. See full prescribing information for LATISSE. LATISSE ® (bimatoprost ophthalmic solution) 0.03% , for topical ophthalmic use Initial U.S. Approval: 2001
Medication labelWhy this: Advisory · dailymed-prescription
LATISSE ® (bimatoprost ophthalmic solution) 0.03% is indicated to treat hypotrichosis of the eyelashes by increasing their growth including length, thickness and darkness.
- generic_name
- bimatoprost
- product_names
- bimatoprost
- ndc
- 0023-3616, 0023-3616-71, 0023-3616-05, 0023-3616-70
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en